Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Frances F. Wang"'
Autor:
Laura H. Hendrix, Haley A. Moss, Frances F Wang, Mihaela V Georgieva, Michaela A. Dinan, Laura J. Havrilesky
Publikováno v:
Journal of oncology practice. 15(12)
PURPOSE: Efforts to curb the rising costs of cancer care while improving quality include alternative payment models (APMs), which offer incentives to reduce avoidable spending and provide high-quality and cost-efficient care. The impact of proposed A
Autor:
George Fedoriw, Endi Wang, Chuanyi M. Lu, Elizabeth L. Boswell, Frances F. Wang, Deepti M. Reddi, Yen-Chun Liu, Abner Louissaint, Scott Ely, Murat O. Arcasoy, Barbara K. Goodman
Publikováno v:
American Journal of Clinical Pathology. 138:855-866
We describe 41 cases of myeloid neoplasms (MNs) secondary to plasma cell myeloma (PCM). The types of MN included myelodysplastic syndrome (MDS) in 34 (82.9%), acute myeloid leukemia (AML) in 4 (9.8%), and myeloproliferative neoplasm (MPN) or MDS/MPN
Autor:
Charles Blake Hutchinson, Patrick J. Buckley, Jingwei Yu, Jennifer H. Crow, David A. Rizzieri, Michael B. Datto, Frances F. Wang, Qin Huang, Anand S. Lagoo, Barbara K. Goodman, Siby Sebastian, Catherine Rehder, Endi Wang, Mitchell E. Horwitz, Chuanyi M. Lu
Publikováno v:
American Journal of Clinical Pathology. 135:525-540
We report 10 cases of donor cell leukemia (DCL). All cases except the case of chronic lymphocytic leukemia had anemia, neutropenia, and/or thrombocytopenia when DCL was diagnosed. Eight cases with sex-mismatched hematopoietic stem cell transplant (HC
Autor:
John A. Papalas, Siby Sebastian, Maggie Stoecker, Michael B. Datto, Frances F. Wang, Charles Blake Hutchinson, James L. Burchette, Endi Wang
Publikováno v:
Leukemialymphoma. 53(5)
While the majority of patients with early-stage mycosis fungoides (MF) have an excellent prognosis, a few cases progress to secondary Sezary syndrome (sSS), which carries a dismal clinical outcome. We retrospectively analyzed 135 cases of MF/SS and c
Autor:
Endi, Wang, Charles Blake, Hutchinson, Qin, Huang, Chuanyi Mark, Lu, Jennifer, Crow, Frances F, Wang, Siby, Sebastian, Catherine, Rehder, Anand, Lagoo, Mitchell, Horwitz, David, Rizzieri, Jingwei, Yu, Barbara, Goodman, Michael, Datto, Patrick, Buckley
Publikováno v:
American journal of clinical pathology. 135(4)
We report 10 cases of donor cell leukemia (DCL). All cases except the case of chronic lymphocytic leukemia had anemia, neutropenia, and/or thrombocytopenia when DCL was diagnosed. Eight cases with sex-mismatched hematopoietic stem cell transplant (HC
Publikováno v:
Leukemia research. 24(8)
Chronic lymphocytic leukemia (CLL) is rare in Asians living in Asia and possibly in US Asians. In contrast, CLL is the most common leukemia in whites. The basis for this ethnic and geographic variation is unknown. We compared average annual age-adjus
Autor:
Meernik C; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina., Wang F; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina., Raveendran Y; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina., Green MF; Department of Pathology, Duke University School of Medicine, Durham, North Carolina., Check DK; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina., Bosworth HB; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina.; Division of General Internal Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.; Duke University School of Nursing, Duke University School of Medicine, Durham, North Carolina., Sutton LM; Duke Cancer Network, Duke Cancer Institute, Durham, North Carolina., Strickler JH; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina., Akinyemiju TF; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Nov 01; Vol. 4 (11), pp. 2968-2975.
Autor:
Epplein M; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina, USA.; Department of Population Health Sciences, Duke University, Durham, North Carolina, USA., McCall SJ; Department of Pathology, Duke University, Durham, North Carolina, USA., Wang F; Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina, USA., Alagesan P; School of Medicine, Duke University, Durham, North Carolina, USA., Brown H; Department of Medicine, Duke University, Durham, North Carolina, USA., Wawrzynski J; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina, USA., Labriola C; School of Medicine, Duke University, Durham, North Carolina, USA., Zuzul R; School of Medicine, Duke University, Durham, North Carolina, USA., Cook C; School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA., Dillon M; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hyslop T; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina, USA.; Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina, USA.; Division of Biostatistics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Patierno SR; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina, USA.; Department of Medicine, Duke University, Durham, North Carolina, USA., Salama NR; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Garman KS; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina, USA.; Department of Medicine, Duke University, Durham, North Carolina, USA.; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina, USA.
Publikováno v:
Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2024 Jun 01; Vol. 15 (6), pp. e1. Date of Electronic Publication: 2024 Jun 01.
Autor:
Sekaya G, Wang F; the Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina., Brown H; the Department of Medicine, Division of Gastroenterology, Duke University, Durham, North Carolina., Alagesan P; the Department of Medicine, Division of Gastroenterology, Duke University, Durham, North Carolina., Batch BC; the Department of Endocrinology and Metabolism, Duke University, Durham, North Carolina., Garman KS, Epplein M
Publikováno v:
Southern medical journal [South Med J] 2024 Apr; Vol. 117 (4), pp. 199-205.
Autor:
Garman KS; Division of Gastroenterology, Department of Medicine, Duke University, Durham, NC, USA.; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, 2424 Erwin Road, Suite 602, Durham, NC, 27705, USA., Brown H; Duke University School of Medicine, Durham, NC, USA., Alagesan P; Duke University School of Medicine, Durham, NC, USA., McCall SJ; Department of Pathology, Duke University, Durham, NC, USA., Patierno S; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, 2424 Erwin Road, Suite 602, Durham, NC, 27705, USA.; Departments of Medicine, Family Medicine and Community Health, and Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Wang Q; Department of Biostatistics & Bioinformatics, Duke University, Durham, NC, USA., Wang F; Department of Biostatistics & Bioinformatics, Duke University, Durham, NC, USA., Hyslop T; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, 2424 Erwin Road, Suite 602, Durham, NC, 27705, USA.; Department of Biostatistics & Bioinformatics, Duke University, Durham, NC, USA.; Department of Biostatistics, Thomas Jefferson University, Philadelphia, PA, USA., Epplein M; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, 2424 Erwin Road, Suite 602, Durham, NC, 27705, USA. meira.epplein@duke.edu.; Department of Population Health Sciences, Duke University, Durham, NC, USA. meira.epplein@duke.edu.
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2024 Jan; Vol. 27 (1), pp. 28-35. Date of Electronic Publication: 2023 Nov 20.